Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Financings In Brief

This article was originally published in The Gray Sheet

Executive Summary

Dehaier Medical Systems goes public: Developer of medical devices for the Chinese market goes public through a $12 million offering of 1.5 million shares at $8 each, completed April 22. The firm assembles branded products at its Beijing facility from components made by third parties, and also distributes finished products made by other companies. Offerings include x-ray, anesthesia and patient monitoring systems, as well as home respiratory and oxygen products. Proceeds from the initial public offering are tabbed for R&D, marketing, potential acquisitions and working capital. The shares trade on the Nasdaq exchange under the symbol "DHRM." Anderson & Strudwick was placement agent for the offering

You may also be interested in...

Spine Deal Redux: Alphatec Makes Another Go At Acquiring Scient'x

Alphatec Spine aims to significantly expand its international sales presence and create the third-largest independent spinal device firm through its $116 million acquisition of French spinal implant company Scient'x

The Quality Lowdown: On Redeploying Inspectors, API Suppliers Thanks To Coronavirus

US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.

Mallinckrodt's Opioid Resolution Through Generic Unit Bankruptcy May Be 'Test Case'

Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts